弹性阻力可能决定神经肌肉阻滞对急性呼吸窘迫综合征死亡率的影响
该研究为ROSE试验的二次分析,采用贝叶斯逻辑回归评估基线呼吸系统弹性阻力(Ers)等生物标志物对早期神经肌肉阻滞(NMB)90天死亡率效应的修饰作用。结果显示NMB的生存获益随基线Ers升高而增大,Ers≥2 cm H2O/(ml/kg)患者获益后验概率96%,而通气比及血浆生物标志物未见有意义修饰。
要点
- 基线Ers越高,NMB降低90天死亡率的获益越明显。
- Ers≥2 cm H2O/(ml/kg)患者NMB获益后验概率96%,绝对风险降低中位数9%。
- 通气比及RAGE、TNFR-1、IL-6、IL-8对NMB效应无有意义修饰。
核心结论
- NMB对90天死亡率的获益随基线呼吸系统弹性阻力(Ers)升高而增大。
- 高Ers可能代表急性呼吸窘迫综合征的一种生理表型。
研究设计与样本
- 研究为ROSE试验的二次分析。
- 采用贝叶斯逻辑回归模型估计基线Ers、通气比及部分ARDS血浆生物标志物对NMB效应的修饰作用。
主要发现
- NMB死亡获益随基线Ers升高而增加,交互作用后验概率92%,交互作用比值比0.76(90%可信区间0.59-0.99)。
- Ers≥2 cm H2O/(ml/kg)患者获益后验概率96%,绝对风险降低中位数9%(90%可信区间0.5-17.9)。
- NMB效应未随通气比(交互作用后验概率62%)或RAGE、TNFR-1、IL-6、IL-8血浆水平(交互作用后验概率分别为12%、18%、44%、22%)出现有意义变化。
临床怎么用
- 对高Ers的ARDS患者,可考虑早期使用NMB以潜在降低90天死亡率。
- 低Ers患者从NMB中获益的证据较弱,决策需结合个体情况。
局限性
- 本研究为二次分析,结论需前瞻性试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Patients with acute respiratory distress syndrome (ARDS) have a reduction in functional lung volume that results in increased respiratory system elastance (Ers); however, the extent of this increase varies by patient. Patients with high Ers are at risk of excess lung-distending pressures and may derive greater clinical benefit from neuromuscular blockade (NMB). Objectives: We sought to evaluate whether the effect of early NMB administration on mortality varies according to baseline physiological and biological biomarkers of lung injury, including Ers. Methods: We conducted a secondary analysis of the Reevaluation of Systemic Early Neuromuscular Blockade, or ROSE, trial. Bayesian logistic regression modeling was used to estimate the posterior probability of NMB effect moderation by baseline Ers, ventilatory ratio, and select ARDS plasma biomarkers on 90-day mortality. Measurements and Main Results: The probability of mortality benefit with NMB increased substantially with higher baseline Ers (posterior probability of interaction, 92%; interaction odds ratio = 0.76; 90% credible interval = 0.59-0.99). In patients with an Ers ⩾2 cm H2O/(ml/kg), the posterior probability of benefit was 96% (median absolute risk reduction, 9%; 90% credible interval = 0.5-17.9). The effect of NMB did not vary meaningfully according to ventilatory ratio (posterior probability of interaction, 62%) or baseline plasma levels of receptor for advanced glycation end-products, tumor necrosis factor receptor-1, IL-6, or IL-8 (posterior probabilities of interaction: 12%, 18%, 44%, and 22% respectively). Conclusions: These findings suggest that the mortality benefit of NMB varies with baseline Ers. High Ers may represent a physiological phenotype of acute respiratory distress syndrome. Future prospective testing to confirm benefit in this potentially treatment-responsive group is needed.
引用
- Zalucky AA, Dianti J, Neyton LPA, et al. Elastance May Determine the Neuromuscular Blockade Effect on Mortality in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2025. PMID: 39998496. doi:10.1164/rccm.202406-1231OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。